(Q24199151)

1

0 references

Martin Aigner

2

0 references

Michael Ossege

3

0 references

Elisabeth Pernicka

4

0 references

Thomas Sycha

Cochrane Database of Systematic Reviews

6

0 references

publication date

29 August 2013

0 references

published in

0 references

cites work

Tiapride versus glafenine: a double-blind comparative study in the management of acute rheumatic pain.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Haloperidol as an adjunct analgesic in the management of postoperative pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Pimozide therapy for trigeminal neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

A randomized clinical trial to assess the efficacy of intramuscular droperidol for the treatment of acute migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Fluphenazine for Tension Headache; Double-Blind Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Olanzapine versus droperidol for the treatment of primary headache in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Randomized evaluation of octreotide vs prochlorperazine for ED treatment of migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Symptomatic relief with flupentixol (Fluanxol) of the anxious-algetic-depressive syndrome complex in neurotic states. A double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Avoiding psychic adverse effects during induction of neurolept anaesthesia with levomepromazine. A double-blind study of levomepromazine and droperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Prophylactic antiemetics for laparoscopic cholecystectomy: a comparison of perphenazine, droperidol plus ondansetron, and droperidol plus metoclopramide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Droperidol vs prochlorperazine for the treatment of acute headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Psychotropic adjuvant analgesics for pain in cancer and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Comparison of fentanyl and droperidol mixture (neuroleptanalgesia II) with morphine on clinical outcomes in unstable angina patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Olanzapine in the management of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Olanzapine for the treatment of fibromyalgia symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Pharmacological approaches other than opioids in chronic non-cancer pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

The neuroleptics as adjuvant analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Antinociceptive mechanism of L-DOPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Olanzapine in the treatment of refractory migraine and chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Antipsychotics for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

Repetitive Intravenous Prochlorperazine Treatment of Patients With Refractory Chronic Daily Headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

[Chronic facial pain from psychiatric point of view - differential diagnosis and therapeutic strategies]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

7 January 2021

Biochemical measures in patients with a somatoform pain disorder, before, during, and after treatment with amitriptyline with or without flupentixol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

7 January 2021

Does addition of low-dose flupentixol enhance the analgetic effects of low-dose amitriptyline in somatoform pain disorder?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

7 January 2021

The Atypical Neuroleptics Clozapine and Olanzapine Differ Regarding Their Antinociceptive Mechanisms and Potency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

7 January 2021

Clinical effectiveness of antidepressants and antipsychotics in chronic benign pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

7 January 2021

Fluphenazine/nortriptyline in the irritable bladder syndrome. A double-blind placebo controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

7 January 2021

Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

7 January 2021

Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004844.PUB3

7 January 2021